Sector components forecast to show the biggest earnings year-over-year earnings improvement include Humana Inc. NYSE: HUM, Elevance Health Inc. NYSE: ELV, Incyte Corp. NASDAQ: INCY, Insulet Corp.
A dose of Eli Lilly's diabetes drug Mounjaro has limited availability through February 2024, according to the U.S. Food and Drug Administration's website, due to an increase in demand.
The latest trading day saw Eli Lilly (LLY) settling at $629.68, representing a -0.19% change from its previous close.
An Eli Lilly & Co. LLY, -0.47% experimental gene therapy has restored the hearing of a child who was born deaf, the pharmaceutical giant said Tuesday.
The healthcare industry has long been a compelling space for investors to generate steady returns. DexCom is raking in profits from newly launched products, and its long-term growth story looks bright
Eli Lilly has a lot of debt, but it's to help expand its manufacturing capacity. It doesn't appear to have much cash, but that's because of investments in R&D.
CNBC's Jim Cramer said Tesla may have hit a "growth pause," compared to its Big Tech peers that are still on the rise.
After years of a slowdown in performance and revenue, Eli Lilly (NYSE: LLY) is starting to turn the page. With its innovations in the pharmaceutical sector, most notably in diabetes treatment, its med
Eli Lilly is the largest healthcare company by market capitalization. The company is unlikely to underperform its similarly-sized peers.

Is It Too Late to Buy Eli Lilly Stock?

10:30am, Sunday, 21'st Jan 2024
Eli Lilly's stock has been soaring due to the excitement around Zepbound. The stock's high valuation, however, could be a concern for value-oriented investors.
Eli Lilly just wrapped up a great year for shareholders, and there may be an encore in 2024. The company is going to continue its business development bonanza.
Eli Lilly has outperformed Meta Platforms in recent years. The biotech leader has excellent mid-term prospects.
CRISPR Therapeutics stock has room to run higher with the biotech's first therapy on the market. Eli Lilly is now the world's biggest drugmaker and has multiple growth drivers.
U.S. inspectors recently uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by federal investigators, according to government records obtained by Reuters.
Eli Lilly (LLY) reachead $628.91 at the closing of the latest trading day, reflecting a -0.89% change compared to its last close.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE